Merck Co - aktuální graf a vývoj ceny
Merck and Gilead among drug stocks buoyed by Trump's healthcare plans
Merck and Gilead among drug stocks buoyed by Trump's healthcare plans Proactive Investors USA & Canada - 22 hours ago US drugs giants Merck & Co Inc (NYSE:MRK) and Gilead Sciences Inc (NASDAQ:GILD) were among those to make large gains on Thursday following the release of the Senate Republicans' healthcare plan. Iberiabank Maintains Holding in Peoples United Financial (PBCT), As Gilead ... - San Times23. 06. 2017
Merck: Why The Small Dividend Hikes?
Merck: Why The Small Dividend Hikes? Seeking Alpha - Jun 15, 2017 Merck's dividend was never cut after the crisis but it hasn't grown much either. Merck has lots of priorities for its cash and as a result, its dividend takes a back seat to an extent. Merck & Co., Inc. (MRK): What's the Story? - StockNewsJournal Merck & Company Inc. (new) (MRK) Closes 0.16% Up on the Day for June 14 - Equities.com15. 06. 2017
Merck Reveals Its Gastric Cancer Hand
Merck Reveals Its Gastric Cancer Hand Seeking Alpha - Jun 6, 2017 Merck & Co (NYSE:MRK) recently made an audacious bid to gain early approval for Keytruda in gastric cancer, potentially outmaneuvering immuno-oncology competitors with the first regulatory OK, and the data backing this were disclosed at Asco today. Merck's Cancer Drug Keytruda Positive in Clinical Studies - Zacks.com06. 06. 2017